SARS-CoV-2 (2019-nCoV) S RBD
Anti-SARS-CoV-2 (2019-nCoV) S RBD Recombinant Antibody Products
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human IgG1
- Application: ELISA, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human IgG1
- Application: ELISA, Neut
Compare
-
- Type: Human IgG1
- Application: ELISA, Inhib
Compare
-
- Type: Human IgG1
- Application: ELISA, Inhib
Compare
-
- Type: Human IgG1
- Application: ELISA, Inhib
Compare
-
- Type: Human IgG1
- Application: ELISA, Inhib
Compare
-
- Derivation: Llama
- Type: Camelid VHH
- Application: ELISA, Neut
Compare
-
- Derivation: Humanized
- Species Reactivity: Coronavirus disease 2019
- Type: Humanized IgG
- Application: ELISA, Neut
Compare
-
- Derivation: Humanized
- Species Reactivity: Coronavirus disease 2019
- Type: Humanized IgG
- Application: ELISA
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human IgG1
- Application: ELISA, FC, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human IgG1
- Application: ELISA, IF, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human IgG1
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Rabbit IgG
- Application: ELISA, IF, IHC, WB
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Rabbit IgG
- Application: ELISA, FC
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Rabbit IgG
- Application: ELISA
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG
- Application: ELISA
Compare
-
- Derivation: Llama
- Species Reactivity: Coronavirus disease
- Type: Camelid VHH
- Application: ELISA, Neut
Compare
-
- Derivation: Llama
- Species Reactivity: Coronavirus disease
- Type: Camelid VHH
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: GICA, ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG
- Application: ELISA, Neut, WB
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG
- Application: ELISA, Neut, WB
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Rabbit IgG, κ
- Application: FC, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgM
- Application: ELISA, Neut, WB
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Mouse IgG
- Application: ELISA
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV), SARS-CoV
- Type: Rabbit IgG
- Application: ELISA
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Rabbit IgG
- Application: ELISA, FC, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Mouse IgG1
- Application: ELISA, IHC-P, FC, ICC, IF, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Rabbit IgG
- Application: ELISA
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, FC
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Mouse IgG1
- Application: ELISA
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV), SARS-CoV
- Type: Rabbit IgG
- Application: WB, ELISA, IHC-P, FC, ICC/IF, IP
Compare
-
- Type: Human IgG1
- Application: ELISA, Inhib
Compare
-
- Type: Human IgG1
- Application: ELISA, Inhib
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV), SARS-CoV
- Type: Human IgG1, κ
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, Neut, FC
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, Neut, FC
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, WB
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1,κ
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Rabbit IgG
- Application: WB, ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG
- Application: Neut, ELISA, WB
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG
- Application: Neut, ELISA, WB
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Mouse IgG1
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Mouse IgG2b
- Application: ELISA, Neut
Compare
-
- Species Reactivity: SARS-CoV-2 (2019-nCoV)
- Type: Human IgG1
- Application: ELISA, Neut
Compare
-
- Type: Human scFv
- Application: ELISA, Inhib
Compare
-
- Type: Human scFv
- Application: ELISA, Inhib
Compare
-
- Type: Human scFv
- Application: ELISA, Inhib
Compare
-
- Type: Human scFv
- Application: ELISA, Inhib
Compare
-
- Type: Human scFv
- Application: ELISA, Inhib
Compare
-
- Type: Human scFv
- Application: ELISA, Inhib
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human scFv
- Application: ELISA, FC, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human scFv
- Application: ELISA, IF, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human scFv
- Application: ELISA, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human scFv
- Application: ELISA, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human scFv
- Application: ELISA, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human Fab
- Application: ELISA, FC, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human Fab
- Application: ELISA, IF, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human Fab
- Application: ELISA, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human Fab
- Application: ELISA, Neut
Compare
-
- Species Reactivity: Coronavirus disease
- Type: Human Fab
- Application: ELISA, Neut
Compare
-
- Type: Human Fab
- Application: ELISA, Inhib
Compare
-
- Type: Human Fab
- Application: ELISA, Inhib
Compare
-
- Type: Human Fab
- Application: ELISA, Inhib
Compare
-
- Type: Human Fab
- Application: ELISA, Inhib
Compare
-
- Type: Human Fab
- Application: ELISA, Inhib
Compare
-
- Type: Human Fab
- Application: ELISA, Inhib
Compare
More Infomation
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
The spike (S) glycoprotein of coronaviruses contains protrusions that will only bind to certain receptors on the host cell. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2; DPP4, dipeptidyl peptidase-4; APN, aminopeptidase N; CEACAM, carcinoembryonic antigen-related cell adhesion molecule 1; Sia, sialic acid; O-ac Sia, O-acetylated sialic acid. The spike is essential for both host specificity and viral infectivity. The term 'peplomer' is typically used to refer to a grouping of heterologous proteins on the virus surface that function together. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. The main functions for the Spike protein are summarized as: Mediate receptor binding and membrane fusion; Defines the range of the hosts and specificity of the virus; Main component to bind with the neutralizing antibody; Key target for vaccine design; Can be transmitted between different hosts through gene recombination or mutation of the receptor binding domain (RBD), leading to a higher mortality rate.